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Abstract
Allergic asthma is associated with airway eosinophilia, which is regulated by different T-effector cells. T cells express
transcription factors T-bet, GATA-3, RORct and Foxp3, representing Th1, Th2, Th17 and Treg cells respectively. No study has
directly determined the relative presence of each of these T cell subsets concomitantly in a model of allergic airway
inflammation. In this study we determined the degree of expansion of these T cell subsets, in the lungs of allergen
challenged mice. Cell proliferation was determined by incorporation of 5-bromo-29-deoxyuridine (BrdU) together with 7-
aminoactnomycin (7-AAD). The immunohistochemical localisation of T cells in the lung microenvironments was also
quantified. Local expression of cytokines, chemokines and receptor genes was measured using real-time RT-PCR array
analysis in tissue sections isolated by laser microdissection and pressure catapulting technology. Allergen exposure
increased the numbers of T-bet
+, GATA-3
+, RORct
+ and Foxp3
+ cells in CD4
+CD25
+ and CD4
+CD25
- T cells, with the greatest
expansion of GATA-3
+ cells. The majority of CD4
+CD25
+ T-bet
+, GATA-3
+, RORct
+ and Foxp3
+ cells had incorporated BrdU
and underwent proliferation during allergen exposure. Allergen exposure led to the accumulation of T-bet
+, GATA-3
+ and
Foxp3
+ cells in peribronchial and alveolar tissue, GATA-3
+ and Foxp3
+ cells in perivascular tissue, and RORct
+ cells in alveolar
tissue. A total of 28 cytokines, chemokines and receptor genes were altered more than 3 fold upon allergen exposure, with
expression of half of the genes claimed in all three microenvironments. Our study shows that allergen exposure affects all T
effector cells in lung, with a dominant of Th2 cells, but with different local cell distribution, probably due to a distinguished
local inflammatory milieu.
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Introduction
Asthma is one of the most common chronic diseases world-
wide, with an estimated total prevalence of 5% [1]. Eosinophilic
inflammation is a common characteristic linked closely to allergic
asthma. Beyond eosinophils, different T cells are important
regulators of the inflammatory process in asthma. Indeed, the
lung has an extensive network of antigen-presenting cells that
provide antigen presentation to T cells in lung-associated
lymphoid tissue [2].
CD4
+ T cells are essential regulators of the immune response
and inflammatory diseases. After encountering specific antigen,
they become activated, expand their populations and differentiate
into various effector T cell subsets, such as T helper type 1 (Th1),
Th2, interleukin 17 (IL-17)-producing T helper (Th17) and
regulatory T cells (Treg cells). The development of these cells is
dictated by their specific transcription factors T-bet, GATA-3,
RORct and Foxp3, respectively [3–6]. These cells have been
suggested to regulate different aspects of allergic inflammation. For
example, the development of allergy and the presence of
eosinophilic inflammation are suggested to be driven by a Th2
over-activation, in relation to a reduced Th1 activity [7]. Beyond
these two cell types, Th17 and Treg cells have been proposed to
interact with other T cells, and interrelate with each other, to
determine which type of inflammation is induced [8,9]. However,
no study has directly determined the relative presence, tissue
distribution or surrounding inflammatory milieu of each of these T
cell subsets concomitantly in a model of allergic airway
inflammation.
The aim of the current study was to determine the degree of
expansion of different T cell subsets expressing transcription
factors for Th1, Th2, Th17 and Treg cells, in the lungs of
sensitised mice exposed to allergen. To establish in which
microenvironment these cells reside, immunohistochemistry for
each transcription factor was performed. General lung inflamma-
tion was estimated by measuring the concentration of cytokines
released in the lung. The local inflammatory response in the
microenvironments where different cells were located was
estimated by measuring the expression of 60 inflammatory
cytokine, chemokine and receptor genes using real-time RT-
PCR array in tissue isolated by laser microdissection and pressure
catapulting technology.
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Animals
This study was approved by the Animal Ethics Committee in
Gothenburg, Sweden. The permit number is Dnr442–2008 data
2008-12-12. Male C57BL/6 mice, 5 to 6 weeks old, were
purchased from Taconic (Ry, Denmark). All mice were kept
under standard animal housing conditions and provided with food
and water ad libitum.
Allergen sensitisation and allergen exposure
Mice were sensitised twice, with an interval of five days, by the
intraperitoneal (i.p.) injection of 0.5 ml of 8 mg chicken ovalbumin
(OVA)(Sigma-AldrichH, St Louis, MO, USA) bound to 4 mg
aluminium hydroxide (Sigma-AldrichH) in phosphate buffered
saline (PBS). Eight days after the second sensitisation, the mice
were divided in two groups. Both groups were briefly anesthetised
using isoflurane (Baxter, Deerfield, IL, USA). The exposure group
received an intranasal (i.n.) administration of 100 mg OVA in
25 ml of PBS on five consecutive days, while the control group
received only PBS (Fig. 1A).
Evaluation of newly produced inflammatory cells
BrdU (5-bromo-29-deoxyuridine) is a thymidine analogue that is
incorporated into the DNA during the S-phase of the cell cycle by
replacing thymidine. All mice were given 4 mg of BrdU (BrdU
Flow Kits, BD Pharmingen
TM, San Diego, CA) to label newly
produced cells. BrdU was given at a dose of 0.8 mg in 0.2 ml of
PBS by i.p. injection once a day just after allergen exposure, on
days 1 to 5 of allergen exposure.
Sample collection and processing
Samples were collected 24 hrs after the final OVA exposure.
The animals were deeply anesthetised with a mixture of xylazin
(130 mg/kg, RompunH, Bayer, Germany) and ketamine (670 mg/
kg, KetalarH, Parke-Davis, England). Firstly, animals were
sacrificed by puncturing the right heart ventricle and blood was
collected. Secondly, the mice were tracheotomised and broncho-
alveolar lavage (BAL) was performed by instilling 0.25 ml PBS
through the tracheal cannula, followed by gentle aspiration and a
second lavage with 0.20 ml PBS. An additional 1 ml of PBS was
used to wash away airway lumen inflammatory cells, before the
lungs were perfused and removed to harvest parenchymal
inflammatory lung cells. The left lobe was filled with 1 ml of
Tissue-TekH (Sakura Finetek Europe B.V., 2382 AT, Zoeter-
woude, NL) and PBS containing 20% sucrose (Sigma-AldrichH)
and immediately frozen in liquid nitrogen. The apical lobe was
stored at 280uC and another three lobes, without any connective
tissue, were stored on ice in Hanks balanced salt solution (HBSS)
(Sigma-AldrichH) before use.
Preparation of lung single-cell suspensions
The right lung lobes were weighed and rinsed in a Petri dish
before being transferred to a gentleMACS
TM C Tube (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany) containing 5.0 ml of
HBSS supplemented with 10% fatal calf serum (FCS) (Sigma-
AldrichH), 100 ml Collagenase D solution (final concentration
2 mg/ml) and 20 ml DNase I solution (final concentration 80 U/
ml). The mouse lung was dissociated using a gentleMACS
Dissociator (Miltenyi Biotec) according to the manufacturer’s
instructions. Lung cell pellets were collected, washed in PBS
supplemented with 10% FCS and the cells saved for FACS
analysis. The total number of cells was determined using standard
haematological procedures.
Flow cytometry and gating strategy
Flow cytometric analysis of viable leucocytes, eosinophils
and T cells. Cells were pre-treated with 2% mouse serum
(DAKO) for 15 min to prevent unspecific binding and thereafter
stained with the following antibodies; Fluorescein (FITC) labelled
anti-CD45 (clone 30-F11, BD Biosciences), Peridinin Chlorophyll
Protein Complex (PerCP) labelled anti-CD3e (clone 145-2C11),
Phycoerythrin (PE) labelled anti-CD4 (clone H129.19, BD
Biosciences) and 7-aminoactinomycin (7-AAD) (BrdU Flow
Kits, BD Pharmingen
TM, San Diego, CA) or a matching
isotype control antibody. The cells were incubated for 30 min
at 4uC with the antibodies or isotype controls, followed by two
washes with washing buffer (PBS +10% FCS) and fixed with Fix/
Perm solution (Foxp3 Staining Buffer Set, eBioscience
TM)
overnight at 4uC. The remainder of the protocol is as described
for the intracellular staining below, with the exception of the
antibody addition. Gating was first set on intact cells based on
forward and side scatter characteristics. Viable leucocytes were
identified as 7-AAD
-CD45
+ cells in a gated population based on
Figure 1. Establishment of allergic airway inflammation. A) Schedule of OVA sensitisation (i.p.), OVA exposure (25 ml intranasal instillation: i.n.),
BrdU administration (1 mg i.p.) and tissue sampling in this model of allergic airway inflammation. All animals were sensitised to allergen, but control
animals were exposed to PBS instead of OVA. B) Number of lung tissue CD45
+ CCR3
+ granulocytes (i.e. eosinophils) per gram of tissue after OVA/PBS
or OVA/OVA exposure, Data is shown as mean 6 SEM, n = 5–8 mice/group, ***, p,0.001.
doi:10.1371/journal.pone.0019889.g001
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identified as CD45
+CCR3
+SSC
high; T lymphocytes were iden-
tified as CD45
+CD3
+ cells; CD4
+ T cells were identified as
CD45
+CD3
+CD4
+ cells.
Flow cytometric cell cycle analysis of newly produced and
proliferating T helper cell subsets. Lung cells were collected
as described above for the staining of different T helper cells, Th1
cells (CD4
+CD25
+T-bet
+), Th2 cells (CD4
+CD25
+GATA-3
+),
Th17 cells (CD4
+CD25
+RORct
+) and Treg cells (CD4
+
CD25
+Foxp3
+). Cells were stained with following antibodies;
FITC labelled anti-CD4 (clone RM4-5, BD Biosciences) and
Alexa FluorH 700 labelled anti-CD25 (clone PC61, BioLegend,
San Diego, CA) or a matching isotype control antibody. Cells were
fixed and intracellular staining performed according to the
manufacturer’s protocol for the Foxp3 staining buffer set
(eBioscience
TM). Intracellular antibodies used included PE
labelled anti-T-bet (clone eBio4B10, eBioscience
TM), PE labelled
anti-GATA-3 (clone TWAJ, eBioscience
TM), PE labelled anti-
RORct (clone AFKJS-9, eBioscience
TM) and PE labelled anti-
Foxp3 (clone FJK-16s, eBioscience
TM). The subsequent
intracellular staining for BrdU and 7-AAD was performed using
BrdU Flow Kits (BD Pharmingen
TM, San Diego, CA) according to
the manufacturer’s instructions. BrdU was used to identify the
newly produced cells and 7-AAD was used as a DNA dye to
identify the proliferation of newly produced cells in situ. All flow
cytometry analyses were carried out using a BD FACSAria
TM
Flow Cytometer (BD Biosciences, San Jose, CA) with 150 000
events being acquired per sample and analysed with FlowJo
SoftwareH (Tri star Inc, Ashland, OR, USA). Due to the cell size
and characteristic profile, the non-granulocytes (mononuclear
cells) were gated under the intact cells, as described above. CD4
+
cells were gated based on forward and side scatter characteristics
and isotype control.
Lung histology
The left lobe of the lung was embedded in Tissue-TekH O.C.T.
Compound (Miles, Inc., Elkhart, IN, USA), snap-frozen and
stored at 280uC until sliced into 5 mm sections using a cryostat
Leica CM1900 UV-cryostatH (Leica Microsystems Nussloch
GmbH, Germany).
Eosinophils
Eosinophils were identified by immunostaining of the major
basic protein (MBP), an eosinophil granule protein expressed early
in eosinophil-lineage committed cells, as well as in mature
eosinophils. (Kind gift from Dr James Lee, Mayo Clinic,
Scottsdale, AZ, USA). The immunostaining was performed as
described previously [10].
Th1 and Th2 lymphocytes
Tissue sections were fixed for 30 min in 2% formaldehyde,
rinsed in Tris-buffered saline (TBS) and subjected to heat-induced
antigen retrieval using Target Retrieval solution, pH 6 (DakoCy-
tomation, Glostrup, Denmark). Endogenous peroxidase was
blocked with pre-heated (37uC for 30 min) glucose oxidase
solution (PBS supplemented with 0.0064% sodium azide, 0.18%
glucose, 0.1% saponin and 1.55 units of glucose oxidase/ml
PBS)(all from Sigma) by incubation for 30 min. All washes
between the steps were performed using TBS, with or without
Tween 20.
For T-bet staining, the blocking of unspecific binding sites was
performed by incubating the slides with Normal Horse Serum
(ImmPRESS
TM REAGENT, Vector Laboratories, Inc., Burlin-
game, CA). Primary antibodies for the detection of T-bet (rabbit
anti-mouse T-bet, clone H-210, Santa Cruz Biotechnology Inc.)
were applied, followed by a secondary antibody-anti-rabbit Ig-
(ImmPRESS
TM REAGENT, Vector Laboratories, Inc). Bound
antibodies were visualised by 3.39-diaminobenzidine (DAB)
(DAKO Liquid DAB Substrate-Chromogen System, DakoCyto-
mation) and counterstained with Mayer’s Hematoxylin (Sigma). A
matched isotype control was used at the same protein concentra-
tion as the primary antibody.
For GATA-3 staining, the endogenous biotin was blocked by
using the Avidin/Biotin Blocking Kit (Vector Laboratories, Inc.).
The biotinylation of the primary antibody, GATA-3, (Mouse
anti-GATA-3, clone L50–823, BD Pharmingen
TM) was prepared
by the addition of the antibody to the biotin reagent
(DakoCytomation ARK
TM (Animal Research Kit)) which was
incubated for 15 min, followed by the addition of the blocking
reagent. Sections were incubated in the prepared biotinylated
antibody mixture for 20 min, followed by horse radish peroxidise
(HRP) conjugated streptavidin. The detection of the antibody
staining and subsequent counterstaining was performed as above
for T-bet.
T regulatory lymphocytes
For Foxp3 staining, the sections were subjected to heat-induced
antigen retrieval using Antigen Retrieval Reagent Basic (R&D
Systems Inc., Abingdon, UK) for 30 min. The blocking of
endogenous peroxidase was performed as described above, while
the blocking of unspecific binding sites and endogenous biotin was
performed by incubating the slides with 10% Normal Donkey
Serum (Jackson ImmunoResearch Laboratiories. Inc., PA, USA)
followed by the use of the Avidin/Biotin Blocking Kit. The
primary antibody for the detection of Foxp3 (rat anti-mouse/rat
FOXP3, clone FJK-16s, eBiosciences
TM) was applied, followed by
the secondary antibody, biotin-conjugated F(ab’)2 donkey anti-rat
IgG (Jackson ImmunoResearch Laboratories. Inc.) and ExtrA-
vidin-HRP (Sigma). Antibody detection and counterstaining was
performed as above.
Th17 lymphocytes
For RORct staining, tissue sections were fixed with 2%
formaldehyde for 10 min, rinsed in PBS and incubated with
10% Normal Rabbit Serum (Jackson ImmunoResearch Labo-
ratories, Inc.), followed by incubation with rat anti-mouse/
human RORc (t) (ROR gamma, Retinoid-Related Orphan
Receptor gamma) (clone AFKJS-9, eBioscience
TM). Unless
otherwise stated, a TBS-saponin solution was used for all wash
steps. The reaction was visualised by using the APAAP (alkaline
phosphatase anti-alkaline phosphatase) technique with the
bridge antibody, rabbit anti-rat IgG (DAKO, Z0494) and
monoclonal APAAP rat IgG (DAKO, D0488), with each
antibody being applied for 30 min. To increase the staining
intensity, these two steps were repeated. After a final wash with
TBS, bound antibodies were visualised using Liquid Permanent
Red Chromogen (LPR) (DakoCytomation). Counterstaining was
performed as above.
Quantification
The stained samples were assessed in a blinded fashion using an
Axioplan 2 microscope (Carl Zeiss Jena GmbH) at a magnification
of x400. To facilitate counting, a graticule was applied to the
ocular. Eight representative sections of each of the three lung
microenvironments (peribronchial, perivascular and alveolar
tissue), were assessed. Positive cells were counted and the data
expressed as the number of cells/mm
2 [11].
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Cell lysate of the apical lobe of the mouse lung was used for
cytokine measurements. BD Cytometric Bead Array (CBA) Mouse
Th1/Th2/Th17 Cytokine kit (BD Biosciences) was used to
measure IL-2, IL-4, IL-6, IFN-c, TNF, IL-17A and IL-10 in the
lung tissue. Data were acquired on a FACS ARIA and samples
were analysed using FCAP Array Software (BD Biosciences).
Preparation of tissue for laser capture microdissection
(LCM)
The frozen lung tissue is sectioned at 7 mm in a cryostat (Leica
Microsystems Nussloch GmbH, Germany) and a minimum of 10
sections per animal was prepared for LCM. The frozen sections
wereplacedon Nuclease Free – MembraneSlidesNF 1.0PEN (Carl
Zeiss MicroImaginG GmbH, Mu ¨nchen, Germany) and then
stained with Cresyl Violet acetate (Sigma-AldrichH) according to
the instruction ‘‘RNA extraction from frozen section’’ (PALM
Laboratories, ZEISS) . The slides were allowed to air-dry com-
pletely before stored desiccated at 280uC to prevent activation of
endogenous RNase in the tissues.
Laser capture microdissection (LCM)
The Carl Zeiss Laser Microdissection and Pressure Catapulting
(LMPC) technology (http://PALM-microlaser.com) was used, the
specimen was microdissected by a focused laser beam, and then a
defined laser pulse transports the cut piece of the specimen out of
the object plane into a collection device, AdhesiveCap opaque
(Carl Zeiss MicroImaginG GmbH, Mu ¨nchen, Germany). The
lung section to be subjected to LCM was visualised with the
PALM- MicroBeam microscope (Carl Zeiss, Germany) at a
magnification of x 5. Typically, on each tissue section most of the
peribronchial, perivascular and alveolar tissue were obtained and
at least 10 sections were used for each mouse. The time required
was about 3 h/per section.
RNA isolation
LCMcellswerecollectedfromthreedifferentmicroenvironmentsof
three OVA sensitised and exposed (OVA/OVA) mice. Whole lung
tissuesectionof50 mmfromOVAsensitizedandPBSexposed(OVA/
PBS) mouse was used as control. The RNA was extracted using a
QIAGEN RNeasyH Micro Kit (QIAGEN) according to manufactur-
er’s protocol for the purification of total RNA from microdissected
cryosections (QIAGEN). The RNA quality and quantity was
determined using an Agilent Bioanalyzer with a RNA 6000 Nano
Assay (Agilent Technologies, Deutschland GmbH, Waldbronn).
Real-time reverse transcription polymerase chain
reaction (real-time RT-PCR)
RNA from three OVA/OVA mice were pooled based on three
microenvironments whereas RNA from one OVA/PBS mouse
was used as a control. Each cDNA reaction was prepared using the
SABiosciences’s RT
2 First Strand Kit and 135 ng of total RNA
according to the manufacturer’s protocol. Real-time RT-PCR was
carried out using RT
2 Profiler
TM PCR Array (PAMM-0011D)
plates containing 84 mouse inflammatory cytokines, chemokines
and receptor genes from Super array Bioscience Corporation,
USA. SABiosciences’s RT
2 SYBR Green qPCR Master Mix was
used for detection and the array plates were run in a Bio-Rad
CFX96 Real-Time PCR Detection System (Bio-Rad) according to
manufacturer’s instructions (SABioscience). Results were moni-
tored using different controls available on the plates. Gene
expression levels were measured by the threshold cycle (Ct) and
samples showing more than one peak in the melting curve were
excluded from the analysis performed using CFX Manager 2.0
software (Bio-Rad). Twenty-four genes were not considered as
they did not pass our quality control, leaving 60 genes for further
analysis. Data were normalized with five housekeeping genes
[Gusb (Glucuronidase, beta), Hprt1 (Hypoxanthine guanine
phosphoribosyl transferase 1), Hsp90ab1 (Heat shock protein
90kDA alpha (cytosolic), class B member 2), Gapdh (Glyceralde-
hyde-phosphate dehydrogenase), Actb (Actin, beta cytoplasmic)]
available in the plates. Finally, fold-changes compared to the
control mice were calculated using the manufacturer’s software
(SABioscience). A fold-change cutoff $3 was used to identify
molecules whose expression was differentially regulated.
Bioinformatic Analysis
Genes of interest identified using the RT2 ProfilerTM PCR Array
were further analysed by Ingenuity Pathways Analysis (IPA; version
9.0) (IngenuityH Systems, www.ingenuity.com), specifically in regards
to their interactions. The fold change values were compared to the
control. IPA utilises the Ingenuity Pathways Analysis Knowledge
Base (IPA KB), a manually curated database of protein interactions
from the literature, to analyse data. This KB was used to annotate the
genes of interest and reveal their associations.
Data analysis
All data were expressed as mean 6 SEM (standard error of the
mean). Statistical analyses were carried out using a non-parametric
analysis of variance. The Mann-Whitney U test was used to
determine the significant differences between the individual
groups. A p value ,0.05 was considered statistically significant.
Results
Lung eosinophilia after allergen exposure
All animals were sensitised to OVA and exposed to either OVA
or PBS on five consecutive days, with the protocol presented in
Figure 1A. The number of CD45
+CCR3
+SSC
high granulocytes,
representing mature eosinophils, was significantly increased in the
lung tissue after OVA exposure, compared to control PBS
exposure (Figure 1B), confirming that a model of allergic airway
inflammation had been established.
Lung CD4
+ T cell proliferation de novo and in situ after
allergen exposure
The total number of CD4
+ T cells in lungs did not significantly
differ between OVA and PBS exposed mice (Figure 2A). However,
the total number of CD4
+CD25
+ cells in the lung significantly
increased after repeated OVA exposure (Figure 2A). This finding
concurs with other studies, demonstrating that regulatory T cells in
the thymus are exclusively CD25
+, while those in the periphery are
both CD25
+ and CD25
- subsets of mature CD4
+ T cells [12–14].
CD4
+CD25
2Foxp3
+ T cells have indeed been shown to be more
effective than CD4
+CD25
+Foxp3
+ T cells in mediating tolerance,
emphasising their putative importance in vivo [15,16] and
enforcing the importance of determining the presence of both
the CD25
+ and CD25
2 subsets. The expansion of the
CD4
+CD25
+ subset of cells could be explained by local
proliferation in the lung during repeated OVA exposure. An
established FACS method was used to quantify the presence of
newly produced cells by measuring the incorporation of BrdU and
7-AAD [17]. Indeed, both CD4
+CD25
2 and CD4
+CD25
+ cells
proliferated in the lung during allergen exposure (Figure 2C–D),
confirming our hypothesis. As the relative number of
CD4
+CD25
2 cells is larger in the control group, more
CD4
+CD25
2 cells are newly produced (Figure 2D). Thus, cells
Lung Expansion of Th1, Th2, Th17 and Tregs
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+ and CD25
2 CD4 populations are proliferating
in the lung during repeated OVA exposure (S and G2/M phase)
(Figure 2B). Importantly, comparison of the proliferation rate de
novo and in situ revealed a greater number of proliferating
CD4
+CD25
2 T cells (64%) vs. CD4
+CD25
+ T cells (37%) in the
lung during allergen exposure (Figure 2B).
The expression of T cell transcription factors, T-bet
+(Th1),
GATA-3
+( Th2), RORct
+(Th17) and Foxp3
+(Treg) cells in
CD4
+CD25
+ cells in the lung tissue increased after
allergen exposure
The presence of different effector T cells and Treg cells within
the CD4
+CD25
+ cell compartment was determined by FACS
evaluation of the expression of specific transcription factors. The
number of Th1 (CD4
+CD25
+T-bet
+), Th2 (CD4
+CD25
+GATA-
3
+), Th17 (CD4
+CD25
+RORct
+) and Treg (CD4
+CD25
+Foxp3
+)
cells were all significantly expanded in the lung tissue during
allergen exposure (Figure 3A). Interestingly, the majority of the
expanded cells are Th17 cells, followed by Treg, Th2 and Th1
cells. However, when determining the fold increase of Th1, Th2,
Th17 and Treg cell numbers (OVA-OVA/OVA-PBS) we
discovered that the GATA-3 expressing Th2 cells were increased
up to 22 times more compared to any of the other effector T cells
(Figure 3B).
As all of the T effector cells are generated from common naı ¨ve
cells we were interested to evaluate the relevance between them.
The relative change of cells, expressed as a percentage of all CD4
+
Figure 2. Lung CD4
+ cells proliferate de novo and in situ during allergic airway inflammation. A) Total lung CD4
+ and CD4
+CD25
+ cells (per
gram tissue) in sensitised mice exposed either to PBS or OVA on five consecutive days. B) Representative FACS plots showing the CD4
+ CD25
2 and
CD4
+CD25
+ the lung cells that are also positive for BrdU (newly produced) and stained with 7-AAD (DNA) to determine cell-cycle status. Cells (%) are
shown for the indicated gates and quadrants. The two upper plots represent CD4
+CD25
2 cells, and the two lower plots represent CD4
+CD25
+ cells.
The left plots represent data from mice exposed to PBS and the right plots represent data from mice exposed to OVA. Within each plot, the G1 phase
is represented by the upper left quadrant, the G0 phase in the lower left quadrant, and the S, G2/M phase in the upper right quadrant. C) Number of
CD4
+CD25
+ lung cells (per gram tissue) (white column) demonstrating signs of proliferation, as assessed by the incorporation of BrdU (filled column)
and BrdU and 7-AAD (hatched columns) after exposure of mice to PBS or OVA. D) Number of CD4
+CD25
2 lung cells (per gram tissue) (white column)
demonstrating signs of proliferation, as assessed by the incorporation of BrdU (filled column) and BrdU and 7-AAD (hatched columns) after exposure
of mice to PBS or OVA. All data are shown as mean 6 SEM, n = 5–8 mice/group (*** p,0.001, ** p,0.01).
doi:10.1371/journal.pone.0019889.g002
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exposed animals (Figure 3C). For example, a considerable
percentage of CD4
+ cells in OVA/PBS exposed animals did not
express any of above transcription factors, which was lower in
OVA exposed animals. Among the studied transcription factors,
GATA-3, changes drastically in response to OVA exposure, with a
6 fold increase compared to PBS exposure, whereas Foxp3 was
decreased (Figure 3D).
The expression of T cell transcription factors, T-bet
+(Th1),
GATA-3
+(Th2), RORct
+(Th17) and Foxp3
+(Treg) cells in
CD4
+CD25
2 cells in the lung tissue increased after
allergen exposure
Expression of transcription factors for Th1, Th2, Th17 and
Treg cells was observed also in CD4
+ cells lacking the IL-2Ra (the
CD4
+CD25
2 population; Figure 4). The number of Th1 and Th2
cells in the CD4
+CD25
2 cells was significantly increased in the
lung tissue after allergen exposure, while the number of Th17 and
Treg cells also numerically increased, but not significantly. In the
CD4
+CD25
2 cell population, the majority of the cells express
transcription factors for Th17 cells, followed by Th2, Tregs and
Th1 cells (Figure 4A). Evaluation of the fold increase of the cell
numbers revealed that in CD4
+CD25
2 cells, the Th2 cells
dominate, however to a smaller magnitude vs CD4
+CD25
+
(Figure 4B). When the relevant expression of all transcription
factors in CD4
+ cells was calculated, relatively fewer cells express
the transcription factors for Th1, Th2, Th17 and Treg cells in
OVA/PBS animal compared to OVA/OVA animals (Figure 4C).
Calculation of the fold increase also showed that even in the
CD4
+CD25
2 population, GATA-3 was more increased compared
to the changes observed for T-bet, RORct and Foxp3( Figure 4D).
Lung Th1, Th2, Th17 and Treg cells proliferate during
allergic airway inflammation in both the CD4
+CD25
+ and
CD4
+CD25
2 cell populations
As all effector T cells and Treg cells investigated increased
during allergic inflammation, the degree of ongoing proliferation
was also assessed in each cell type, by determining the percentage
of newly produced cells and their cell cycle phase. Allergen
exposure significantly increased the production of new Th1, Th2,
Th17 and Treg cells in both CD25
+ and CD25
2 populations
(Figure 5A–H). However, when the percentage of newly produced
cells in each population is compared, more than 90% of the Th1,
Th2 and Th17 cells (Figure 5A,C,E) and about 80% of the Treg
cells (Figure 5G) are newly produced in the CD4
+CD25
+
population, while only about 60% of the Th1, Th2 and Treg
Figure 3. Expression of T cell transcription factors, T-bet
+(Th1), GATA3
+(Th2), RORct
+ (Th17) and Foxp3
+(Tregs) cells in the
CD4
+CD25
+ cells in lung during allergic inflammation. A) Number of lung CD4
+CD25
+ cells (per gram tissue) expressing T-bet, GATA-3, RORct
and Foxp3 after exposure of mice to PBS or OVA. Data is shown as mean 6 SEM, n = 5–8 mice/group (*** p,0.001, ** p,0.01). B) Fold change of the
total number of lung cells expressing the four different transcription factors (T-bet, GATA-3, RORc and Foxp3) in CD4
+CD25
+ cells after exposure of
mice to OVA compared to PBS. C) Pie chart showing the relative presence of Th1 (T-bet
+) ,Th2 (GATA-3
+),Th17 (RORct
+ ) and Treg (Foxp3
+) T cells
expressed as percentage of CD4
+CD25
+ cells in OVA and PBS exposed animals. TF=transcription Factor. D) The fold change of the relative presence
of Th1 (T-bet
+) ,Th2 (GATA-3
+),Th17 (RORct
+ ) and Treg (Foxp3
+) T cells expressed as percentage of CD4
+CD25
+ cells after exposure of mice to OVA
compared to PBS.
doi:10.1371/journal.pone.0019889.g003
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newly produced in CD4
+CD25
2 population, suggesting that the
presence of the IL-2Ra increases the proliferative activity of
these cells. When the number of newly produced cells in the S-
G2/M phase is examined, more than 95% of the newly
produced Th1 and Th2 cells in both CD25
+ and CD25
2
populations were proliferating in situ, compared to only 65% of
the newly produced Th17 and Treg cells in CD25
+ and CD25
2
populations. Together, these data show that the majority of
Th1, Th2, Th17 and Treg cells in CD25
+ population are newly
produced after allergen exposure, whereas only half of the Th1,
Th2, Th17 and Treg cells in CD25
2 population are newly
produced after exposure. This confirms the proliferative
enhancement in the presence of IL-2 receptor in the lung
during allergen exposure.
Next we estimated the Th1, Th2, Th17 and Treg cells presence
inthe CD4
+cell pool. T effectorcellsinSand G2/Mphasei.e.:Th1
(CD4
+CD25
+/2Tbet
+BrdU
+7-AAD
++), Th2 (CD4
+CD25
+/2 GAT
A-3
+BrdU
+7-AAD
++), Th17 (CD4
+CD25
+/2RORct
+BrdU
+7-A
AD
++) and Treg (CD4
+CD25
+/2Foxp3
+BrdU
+7-AAD
++) cells are
expressed as % of total CD4
+ T cells. Among T effector cells, the
Th2 cells had the higher fold increase after allergen exposure in
both CD25
+ (Th1: 11, Th2: 31, Th17: 8, and Treg: 10) and CD25
2
(Th1: 10, Th2: 23, Th17: 9, and Treg: 10 respectively).
The distribution of T cell transcription factors differs in
the lung tissue during allergic airway inflammation
As shown by FACS, all of the investigated T effector cells and
Treg cells in the lung were increased in numbers, with many in a
proliferative state, during allergic inflammation. It has been
reported that T cells can traffic into the inflamed lung tissue
during allergic inflammation, but their micro environmental
distribution has so far not been investigated. Therefore, we
stained lung tissue from OVA/PBS and OVA/OVA mice for T-
bet (Th1), GATA-3 (Th2), Foxp3 (Treg cells) and RORct (Th17)
expressing cells by immunohistochemistry (Figure 6A), and
quantified their respective presence in three different areas of
the lung, including lung peribronchial tissue, lung perivascular
tissue and lung alveolar tissue. The immunohistochemical
staining of different transcription factor positive cells is docu-
mented in the nucleus in the three different lung compartments of
OVA /OVA animals (Figure 6A). In addition, also MBP
+ cells,
representing eosinophils, were present in the lung tissue of
allergen exposed mice (Figure 6A). The mice acquired a
significant accumulation of T-bet
+,G A T A - 3
+ and Foxp3
+ cells
in the peribronchial, perivascular and alveolar lung tissue after
allergen exposure, while RORct
+ cells increased only in the
alveolar tissue, but not in the peribronchial and perivascular
tissue (Figure 6B). Focusing in T effector cell relevant distribution,
Figure 4. Expression of T cell transcription factors, T-bet
+(Th1), GATA3
+(Th2), RORct
+(Th17) and Foxp3
+(Tregs) cells in the
CD4
+CD25
2 cells in lung during allergic inflammation. A) Number of lung CD4
+CD25
2 cells (per gram tissue) expressing T-bet, GATA-3, RORct
and Foxp3 after exposure of mice to PBS or OVA. Data is shown as mean 6 SEM, n = 5–8 mice/group (*** p,0.001, ** p,0.01). B) Fold change of the
total number of lung cells expressing the four different transcription factors (T-bet, GATA-3, RORc and Foxp3) in CD4
+CD25
2 after exposure of mice
to OVA compared to PBS. C) Pie chart showing the relative presence of Th1 (T-bet
+), Th2 (GATA-3
+), Th17 (RORct
+) and Treg (Foxp3
+) T cells expressed
as percentage of CD4
+CD25
2 cells in OVA and PBS exposed animals. TF=transcription Factor. D) The fold change of the relative presence of Th1 (T-
bet
+), Th2 (GATA-3
+), Th17 (RORct
+ ) and Treg (Foxp3
+) T cells expressed as percentage of CD4
+CD25
2 cells after exposure of mice to OVA compared
to PBS.
doi:10.1371/journal.pone.0019889.g004
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+ cells were predominantly distributed in the alveolar lung
tissue, followed by the peribronchial and perivascular tissue.
GATA-3
+ and Foxp3
+ cells were mainly expressed in the
perivascular tissue, followed by peribronchial and alveolar tissue.
Although the RORct
+ cells were the smallest population detected
in lung tissue, most were distributed in the peribronchial tissue,
followed by the alveolar and perivascular tissue (Figure 6C).
Cytokine concentration in lungs during allergic
inflammation
To determine the general inflammatory milieu in the lung, pro
and anti-inflammatory cytokines, as well as cytokines relevant to
the different T helper cell subsets, were quantified in the lung
supernatant. Specifically, IL-2, IL-6, TNF (tumour necrosis
factor), IFN-c (Th1), IL-4 (Th2), IL-17A (Th17) and IL-10 (Treg)
Figure 5. Lung Th1, Th2, Th17 and Treg cells in CD4
+CD25
+ and CD4
+CD25
2 populations proliferate de novo and in situ during
allergic inflammation. Number of lung CD4
+CD25
+ (A, C, E and G) and CD4
+CD25
2 cells (B, D, F, H) that are expressing transcription factors (TF); T-
bet (A and B; Th1), GATA-3 (C and D; Th2), RORct (E and F; Th17) and Foxp3 (G and H; Treg) and have incorporated BrdU (filled column) or have
incorporated BrdU and also express a double amount of DNA (7-AAD
++; hatched columns) in mice exposed to PBS or OVA. Data are shown as mean
number of cells per gram tissue +SEM. ** p,0.01.
doi:10.1371/journal.pone.0019889.g005
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found in the expression of IL-2 (Figure 7A), whereas both IL-6 and
TNF were significantly increased after allergen exposure, indicat-
ing a general inflammatory status (Figure 7B-C). IFN-c, IL-4 and
IL-17A were all significantly increased, with IL-4 the most
prominently increased, indicating a Th2 activity in the tissue
(Figure 7D). This supports the presence of a Th2-polarised
inflammatory process in the lung environment. It should be noted
that a number of cells, both structural as well as leukocytes have
the capacity to release many of these cytokines.
Evaluation of the gene expression in peribronchial,
perivascular and alveolar lung tissue as a marker of local
inflammatory response
To further evaluate the local inflammatory microenvironment
in the different lung tissue compartments, we used laser capture
microdissected peribronchial, perivascular and alveolar tissue from
OVA/OVA mice and control mice, followed by a real-time RT-
PCR analysis and quantification of expression of 60 different
cytokines, chemokines or respective receptor genes (Figure 8A).
The effect of allergen exposure in all three tissue compartments
was expressed as fold change compared to gene expression in
OVA/PBS animals (OVA-OVA/OVA-PBS). Allergic inflamma-
tion resulted in a wide variation of inflammatory response from
down-regulation (i.e. Il8.8 times in peribronchial tissue) to up-
regulation (i.e. more than 20 fold for Ccl8 in perivascular tissue)
(Table 1).
Only genes that were changed $3 times in at least one tissue
compartment were considered having biological importance and
were involved in a further analysis. Firstly, we evaluated genes
affected by allergic inflammation (Figure 8B). We found that 22
genes were upregulated and 6 genes were downregulated after
allergen exposure. Fourteen of these were changed in all three
compartments. Of these, twelve genes were upregulated (Casp1,
ccl12, ccl20.Ccl24, Ccl7, Ccl8, Cxcl1, Cxcl9, Il13, Il1r2 and
Spp1) and two were downregulated (Il18 and Tnfrsf1a).
Peribronchial and perivascular tissue had change in expression
of three genes in common (Ccl19 and Cxcr3 were upregulated
Il-8rb was downregulated), while peribronchial and alveolar
tissue had changed expression in two gene (Il-6st and Pf4/
Cxcl4), both downregulated. Alveolar and perivascular micro-
environments shared change in expression of four genes (Ccl17,
Ccl9, Il1r1 and Cd40lg) that were all upregulated. Finally, there
were genes that changed only in one compartment, which
included upregulation Ccl11 and Ccr6 in the perivascular
compartment and Ccl4 and Ccr1 in the alveolar compartment,
and downregulation of Ccxl15 in the peribronchial compart-
ment (Figure 8B).
Next we focus on the differences between the three compart-
ments. For analysis we grouped genes in three categories; genes
Figure 7. Cytokine concentration in lung during allergic inflammation. Concentration of IL-2(A), IL-6(B), TNF (C), IFN-c, IL-4, IL-17A and IL-10
(D) was assessed using CBA; Results are expressed as pg/gram lung tissue, in mice exposed to PBS or OVA. Data are shown as mean 6 SEM, *p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0019889.g007
Figure 6. The distribution of T cell transcription factors differs in the lung microenvironments during allergic inflammation. A)
Photographs of immunohistochemistry of MBP (red) in OVA or PBS exposed sensitised mice, T-bet, GATA-3, Foxp3 (brown) and RORct (red) in
peribronchial, perivascular and alveolar tissue after exposure to OVA in sensitised mice. B) Quantification (cells/mm
2) of T-bet, GATA-3, Foxp3 and
RORct expressing cells in different compartments of the lungs, including peribronchial tissue, perivascular tissue and alveolar tissue, after exposuret o
PBS or OVA. Data shown as mean+SEM, *,0.05. C) Pie chart showing the relative distribution of T-bet, GATA-3, Foxp3 and RORct expressing cells in
the different lung compartments after exposure of mice to OVA.
doi:10.1371/journal.pone.0019889.g006
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inflammation and genes from chemokines that can affect T effect
cells migration, as reported in the literature, followed by analysis of
their relationship using Ingenuity Pathways Analysis.
To determine the role in allergic inflammation, 13 genes related
to allergy were included (Figure 9A), revealing differences between
the three compartments. Among them, eotaxin-2 (Ccl24) was the
highest amplified gene and was expressed mainly in perivascular
tissue. Eotaxin-1(Ccl11) was amplified in the same manner, but to
a smaller degree. The main Th2 cytokine, Il13, was also expressed
in all three compartments with emphasis in alveolar tissue. This
was also seen for Spp1 (osteopontin), which showed a greater
increase compare to Il13. Il18 was downregulated in all
compartments, while Il8rb (Cxcr2) was downregulated mainly in
the peribronchial and perivascular areas. Direct and indirect
relationships between some of these allergy-associated genes was
documented (Figure 9B).
Our final goal was to describe the expression of chemokine
genes that may have a role in the homing of Th1, Th2, Th17 and
Treg cells to different compartments. The Th1 related chemokines
Ccl7, Ccl2 and Cxcl9 were increased in all three compartments
after allergen exposure, with two of them increased in alveolar
tissue (Ccl7, Ccl2). Interestingly Pf4 (Cxcl4) was down-regulated.
Among the Th2 related chemokines, Ccl8 showed the higher fold
increase mainly in perivascular and then in peribronchial tissue.
For Th17, Ccl20 was increased mainly in perivascular tissue. The
Ccl4 a chemokine (Il17-related) was increased mainly in alveolar
tissue. Finally Ccl19, a Treg cell related chemokine was increased
mainly in perivascular tissue supporting immunohistochemistry
data (Figure 10A).
Analysis with ingenuity showed also a complex relation between
the majority of above chemokines, supporting the concept of a
sophisticated network of high complexity and high complexity and
interaction (Figure 10B).
Figure 8. Expression of inflammatory cytokine, chemokine and receptor genes in the lung after allergen exposure compared to
control. A) The different lung tissue compartments (alveolar, perivascular and peribronchial) were isolated from lung tissue from OVA or PBS
exposed mice using the PALM microBeam microscopy. Lung compartment samples were taken from three different animals and then pooled. RNA
was extracted and the inflammatory response in each microenvironment was assessed using real-time RT-PCR array of 84 inflammatory cytokines,
chemokines and receptors. The expression of these genes in each compartment is visualized as heat map. Red colour indicates up-regulated genes,
green colour indicates down-regulated genes, and the dark colour indicates great fold change. B) Venn diagram of genes with fold change $3 times
after allergen exposure in at least one tissue compartment compared to control. Up-regulated genes are shown in red font and down regulated
genes are shown in green font.
doi:10.1371/journal.pone.0019889.g008
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Our current study shows that airway exposure to allergen in
sensitised mice expands all studied effector T cells in the lungs,
including T-bet
+, GATA-3
+, RORct
+ and Foxp3
+ cells , both in
those cell populations expressing the IL-2Ra (i.e. CD25) and those
that do not. Among these, the GATA-3 effector Th2 cell is the one
most prominently increased after allergen exposure, followed to a
lesser extent by the T-bet
+ Th1 and the RORct
+ Th17 cells. In
contrast, the Foxp3
+ Treg cells increased in absolute cells numbers
in the CD4
+CD25
+ and CD4
+CD25
- population but decreased
compare to other T effector cells in the CD4
+CD25
+ fraction. All
effector T cells are produced de novo and proliferate in situ in the
lungs, but with different profiles. Th1 and Th2 cells proliferate
more extensively than Th17 and Treg cells during allergic
inflammation. Allergen exposure subsequently results in an
accumulation of Th1, Th2 and Treg cells in the peribronchial
tissue, as well as an increase in the alveolar lung tissue of Th17
cells. In perivascular tissue, only Th2 and Treg cells increase. A
general inflammatory milieu in the lung was showed to involve
Th2 cytokines such as IL-4 as well as Th1 cytokines including
IFN-c, and the Th17 cytokine IL-17 as well as several pro-
inflammatory cytokines including IL-6. The low concentration of
IL-10 argues for a relatively low activity of Treg cells. Finally,
allergen exposure induced a wide range of inflammatory genes in
lung, whereas some of them only in specific tissues, arguing for the
importance of the local microenvironment. Several chemokine
genes supported the accumulation pattern of T effector cells.
As far as we know this is the first time that all mentioned T cells
are quantified simultaneously in allergic airway inflammation,
especially as both their numbers and their topographical
localizations are determined, as well as their proliferative status.
Furthermore, this is also the first time that the local inflammatory
milieu in three main lung tissue compartments, i.e. peribronchial,
perivascular and alveolar tissue, is described in relation to the
relative expression of a substantial number of relevant pro- and
anti-inflammatory genes.
CD25 (IL-2Ra) expression is induced upon T cell activation to
form part of the trimeric, high affinity IL-2R complex in
combination with CD122 (IL-2Rb) and CD132 (IL-2Rc) and
Table 1. Fold change of gene expression in peribronchial,
perivascular and alveolar lung tissue of OVA exposed mice
compared to PBS control.
RefSeq* Symbol Peribronchial Perivascular Alveolar tissue
NM_013854 Abcf1 2,17 2,03 2,22
NM_009744 Bcl6 1,21 21,09 21,09
NM_009778 C3 1,65 1,34 1,22
NM_009807 Casp1 4,96 6,05 7,36
NM_011329 Ccl1 1,60 2,25 1,73
NM_011330 Ccl11 2,95 4,34 2,73
NM_011331 Ccl12 3,86 3,94 3,63
NM_011332 Ccl17 2,08 3,41 4,08
NM_011888 Ccl19 3,03 6,67 1,84
NM_011333 Ccl2 4,86 5,73 12,13
NM_016960 Ccl20 5,13 9,11 6,23
NM_019577 Ccl24 3,92 13,07 3,63
NM_013652 Ccl4 2,87 2,48 4,56
NM_013653 Ccl5 1,05 1,96 1,97
NM_009139 Ccl6 21,47 21,04 1,64
NM_013654 Ccl7 8,57 11,62 15,78
NM_021443 Ccl8 18,38 20,08 11,08
NM_011338 Ccl9 2,53 3,03 4,23
NM_009912 Ccr1 1,51 2,69 3,39
NM_009915 Ccr2 22,07 21,11 21,32
NM_009914 Ccr3 21,01 1,10 1,04
NM_009916 Ccr4 21,17 1,42 1,51
NM_009835 Ccr6 2,22 3,83 1,79
NM_009913 Ccr9 2,38 2,29 2,89
NM_009142 Cx3cl1 21,66 22,06 22,03
NM_008176 Cxcl1 5,13 4,95 6,23
NM_021704 Cxcl12 21,57 21,22 1,09
NM_011339 Cxcl15 23,14 22,81 21,48
NM_019932 Pf4 24,29 22,62 23,53
NM_009141 Cxcl5 2,08 22,32 21,95
NM_008599 Cxcl9 5,10 6,81 4,69
NM_009910 Cxcr3 2,99 4,43 2,62
NM_008348 Il10ra 21,65 21,37 21,21
NM_008349 Il10rb 1,01 1,35 1,46
NM_008355 Il13 4,08 4,95 6,02
NM_133990 Il13ra1 1,44 21,55 21,77
NM_008357 Il15 21,18 1,32 1,42
NM_008360 Il18 28,11 25,99 26,68
NM_010554 Il1a 21,06 21,19 1,11
NM_008361 Il1b 22,50 21,95 21,21
NM_008362 Il1r1 2,36 3,63 3,27
NM_010555 Il1r2 3,05 3,63 3,46
NM_008368 Il2rb 22,46 21,59 22,03
NM_013563 Il2rg 21,62 1,16 21,23
NM_008370 Il5ra 2,14 2,07 2,60
NM_010560 Il6st 23,18 22,74 23,20
NM_009909 Il8rb 26,15 26,37 22,87
NM_008401 Itgam 1,07 1,25 1,75
RefSeq* Symbol Peribronchial Perivascular Alveolar tissue
NM_008404 Itgb2 1,80 2,88 2,69
NM_010735 Lta 1,33 1,12 21,21
NM_008518 Ltb 21,26 1,33 21,17
NM_010798 Mif 1,92 1,80 1,36
NM_007926 Scye1 1,56 1,49 1,01
NM_009263 Spp1 5,86 9,63 11,55
NM_011577 Tgfb1 22,38 21,62 21,30
NM_011609 Tnfrsf1a 23,07 23,64 23,61
NM_011610 Tnfrsf1b 22,28 22,33 22,64
NM_011616 Cd40lg 2,79 3,97 3,39
NM_023764 Tollip 21,68 21,81 21,58
NM_011798 Xcr1 1,20 1,31 1,45
Genes showed have fulfilled all quality criteria, including Ct value, melting curve
and melting temperature.
*RefSeq, reference sequence.
doi:10.1371/journal.pone.0019889.t001
Table 1. Cont.
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CD25 is involved in T cell proliferation, activation induced cell
death, as well as the actions of both Treg and effector T cells
[19,20]. Soper et al. have shown that transgenic mice lacking IL-
2Ra have unchanged amounts of Tregs in periphery compared to
wild type mice, while mice lacking IL-2Rb did not, suggesting that
IL-2 can be effective even without expression of CD25[21]. These
findings were confirmed in a recent human study, where the
administration of a humanized anti-CD25 antibody in children
undergoing liver transplantation did not affect the circulating
Tregs, proposing that the needed IL-2 signal could be mediated by
the IL-2 bc dimeric receptor [22]. Together, these findings argue
that the CD25
2 cells may still use the IL-2 cytokine for their
maintenance. However, it is not known whether they are as
effective as the CD25
+ cells in regulating immune response.
Furthermore, CD25
2 cells may have other important functions.
For example, CD4
+CD25
2Foxp3
+ cells has been suggested to be
more effective than CD4
+CD25
+Foxp3
+ cells in delivering T-cell
mediated tolerance [15]. Similarly, CD4
+CD25
2 peripheral Treg
cells showed preventive functions in the induction of autoimmune
responses [16]. These previous findings urged us to quantify not
only the CD25
+ CD4 cells, but also the CD25
2 fraction of CD4
+
T cells. In this study, allergen exposure increase the number of
CD4
+ cells that express CD25 from 5% to approximately 25% of
CD4
+ cells in the lungs, confirming its role in allergic
inflammation. Importantly, both the CD25
+ and the CD25
2
populations are proliferating in the lung, although more
prominently in the CD25
+ cell population, arguing for a key role
of IL-2 in this specific cellular process. An explanation of the
proliferation of the CD25
2 cells could be that the cells have shed
their IL-2 receptor after having unchanged proliferation. Indeed,
CD25 is up-regulated on recently activated effector T cells, but
this molecule is subsequently released into the microenvironment
[23].
Figure 9. Gene expression in lung microenvironments during allergic inflammation. A) Fold change of genes related to allergic
inflammation in peribronchial, perivascular and alveolar tissue. Fold change is calculated by comparing OVA exposed mice to PBS control. 3 fold
change threshold indicated by dotted line was considered biological relevant. B) Network of differentially expressed genes in OVA exposed mice
compared to the PBS exposed controls. A network of genes associated with allergic inflammation, generated by Ingenuity Pathways Analysis (3.0 fold
change threshold), of OVA/OVA mice compared to OVA/PBS mice. The expression of these genes in three lung microenvironments was examined;
peribronchial, perivascular and alveolar tissue. Lines indicate relationships between molecules (solid line=direct interaction; dashed line=indirect
interaction). Arrows at the end of these lines indicate the direction of the interaction. Molecules that are up-regulated and down-regulated in the
dataset are coloured red and green respectively. Darker colouring of the molecules indicates a higher fold change. Grey molecules did not meet the
threshold of 3 fold change. Uncoloured molecules have been added from the Ingenuity Knowledge Base. The exact fold change values of each
molecule are shown in Table 1.
doi:10.1371/journal.pone.0019889.g009
Lung Expansion of Th1, Th2, Th17 and Tregs
PLoS ONE | www.plosone.org 13 May 2011 | Volume 6 | Issue 5 | e19889During the past two decades, the Th1/Th2 paradigm of a
balance to regulate development of allergy has prevailed, and
these two cell types have been implicated in the pathogenesis of
different inflammatory diseases including asthma. However, recent
evidence suggests that the dichotomous view of Th-cells
differentiation must be broadened to several other T-cells. In
fact, IL-17-producing Th17 cells appear to play a critical role in
autoimmunity and neutrophilic inflammation [24]. Furthermore,
anti-inflammatory processes have been suggested to involve Treg
cells that suppress the functional activity of other effector T-cells
[25–27]. However, their relative presence in lung tissue in allergic
inflammation has not previously been described. The current
study is thus the first to document the changes in Th1, Th2, and
Th17 and Treg cells in the lung during allergic airway
inflammation. Interestingly, all cells increase in number, but most
prominently the Th2 cells, support their major functional role in
allergic inflammation.
Even though a relative reduction of Foxp3 cells in the
CD4
+CD25
+ fraction was observed after allergen exposure, it
should be noted that the total number of Foxp3 cells indeed are
increased. Importantly, in the CD4
+CD25
2 fraction, the Foxp3
+
cells are increased both as total and relative numbers. It has been
argued that attenuation of Foxp3 can cause Treg to revert back to
effector T cells, for example Th2-like cells, arguing for plasticity in
this population [28,29]. In the case of Th1 and Th17 cell
populations, both of these change in similar patterns during
allergen exposure. One interesting finding is that the relative
expression of the studied transcription factors is quite small in the
Figure 10. Chemokines related to Th1, Th2, Th17 and Treg cells during allergic inflammation. A) Fold change of genes related to
chemoattractants to Th1, Th2, Th17 and Treg cells in peribronchial, perivascular and alveolar tissue. Fold change is calculated by comparing OVA
exposed mice to PBS control. 3 fold change threshold indicated by dotted line was considered biological relevant. B) Network of differentially
expressed genes in OVA exposed mice compared to PBS exposed controls. A network of chemokines, generated by Ingenuity Pathways Analysis (3.0
fold change threshold), of OVA/OVA mice compared to OVA/PBS mice. The expression of these genes in three lung microenvironments was
examined; peribronchial, perivascular and alveolar tissue. Lines indicate relationships between molecules (dashed line=indirect interaction). Arrows
at the end of these lines indicate the direction of the interaction. Molecules that are up-regulated and down-regulated in the dataset are coloured red
and green respectively. Darker colouring of the molecules indicates a higher fold change. Grey molecules did not meet the threshold of 3 fold
change. Uncoloured molecules have been added from the Ingenuity Knowledge Base. The exact fold change values of each molecule are shown in
Table 1.
doi:10.1371/journal.pone.0019889.g010
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+CD25
2 population, as a majority of cells are negative for
any of the transcription factors T-bet, GATA3, RORct and Foxp3
in control animals. However, despite this low baseline expression,
the expression of these transcription factors is relatively increased
during allergen exposure. Additional T helper subsets are being
suggested, and were not identified in the current study, including
Th9 [30], Tr1 [31], Th3 [32] and Th22 cells [33], and some of
these may indeed contribute to the fraction of CD4
+CD25
+ and
CD4
+CD25
2 that do not express any of the currently studied
transcription factors. Clearly, also some of these cells may be
involved in the inflammatory process in this model of allergic
airway inflammation, and warrant investigation in future studies.
All of the effector T cell- and Treg cell- subsets increase their
proliferation in lung during allergen exposure (Figure 5), showing
by uptake of BrdU. However, the CD4 cells that were CD25
+
proliferated to a greater extent than the CD25
2 cells, indicating a
difference in their proliferative ability. Thus, the lung itself is a
microenvironment in which all the different studied T-lympho-
cytes can proliferate. This is documented not only through BrdU
incorporation, but also by cell cycle analysing with 7-AAD,
measuring total amount of DNA in cells (Figure 5), indicating that
many inflammatory cells are in S-phase or G2/M-phase in the
lung during allergic inflammation. Even more, the Th2 cells
showed the greatest increase in proliferation after allergen
exposure, arguing again that these cells are the dominating
effector T cells in allergic inflammation.
Several mechanisms for suppression of T effector cells have
been proposed. Recent observations have suggested that there
could be interaction between different T subsets or with other
inflammatory cells, with or without direct cell-to-cell contact [34–
37]. T cells play a role in both endothelium and epithelium. Our
data showing that allergen exposure result in an increased
accumulation of T-bet
+, GATA-3
+ and Foxp3
+ cells in peribron-
chial tissue, argue that these cells may interact in this
microenvironment. By contrast, T-bet
+ cells accumulate to a
significant extent also in alveolar lung tissue, and to a lesser extent
in perivascular tissue. Further, GATA-3
+ and Foxp3
+ cells are
accumulated primarily in perivascular tissue. These differences in
distribution of T cells argue for the different homing process of
these cells to the different microenvironment, which is a unique
contribution of the current study to the literature.
The lung tissue represents a highly complicated and sophisti-
cated network of many different cells that can react differently to a
variety of stimuli, resulting in unique local inflammatory milieus of
cytokines, chemokines and mediators in different microenviron-
ments. The inflammation itself can of course affect different
subsets of Th-cells that accumulate in different tissue. For
example, it has been shown that NO production from human
airway epithelium can affect the Th1/Th2 balance [38]. Another
possible mechanism can be that the different T-helper cells that
have accumulated in the lungs further drive the inflammation by
further release of cytokines. Lordan et al. have shown that addition
of Th2 cytokines in an already established allergic environment
have the potential to sustain further airway inflammation [39].
To investigate the role of cytokines present in the airways,
cytokines were first quantified in whole lung, showing that allergen
exposure significantly increased levels of pro-inflammatory cyto-
kines such as IL-6 and TNF-a and IL-17, showing the presence of a
general inflammation after allergen exposure. These cytokines may
be produced by a variety of cells as structural cells i.e. epithelial or
fibroblasts or immune cells such as mast cells or eosinophils.
However, it is likely that T cells represent a major source of many of
the measured cytokines, and that Th1 and Th2 cells produce their
corresponding cytokines during proliferation [40].
We decided to take these findings further, to more exactly
determine the local inflammatory milieu in the specific tissue
microenvironment were respective T effector cells were found.
Thus, laser microdissection and pressure catapulting technology
and real-time RT-PCR analysis was combined to document the
presence of expression of a broad range of inflammatory genes,
mainly cytokines and chemokines, in respective tissue. Our data
confirmed the hypothesis that there are differences local inflamma-
tory milieus in the lung tissue compartments during allergic airway
inflammation. Thus, from the 28 genes that had a fold changed $3
times afterallergen exposureonly14, werecommoninallexamined
tissues, whereas some were dominating in respective environment.
Importantly, even among these genes, differences in levels of
expression were documented. For example, eotaxin-2 (Ccl24),
which represents a major chemoattractant for eosinophils, showing
a big variation in its local expression, can possibly explaining the
results of high accumulation of eosinophils in perivascular tissue
[10]. This chemokine may also have cytokine properties, as we have
shown that it can play a role in eosinophilopoiesis locally in the lung
[41]. Another example is the expression of osteopontin (Spp1),
which recently has been proposed to enhance Th2 responses and is
related to human asthma severity [42].
Chemokines plays a major role in T cell trafficking in allergic
and asthmatic inflammation [43]. Therefore it was logical to
hypothesise that local chemokine milieu can affect T effector cells
accumulation. Indeed we have described extensive chemokine
networks expressed in all investigated tissues, but with uneven
expression in the different compartments. The pattern of their
expression can at least partly explain our immunohistochemistry
results. Thus, Th1 reported chemokines such as Ccl17 and Ccl2
[43,44] were primarily expressed in alveolar tissues, where T-bet
cells primarily are located. Ccl8 was quite recently reported by
Islam et al. [45] as a potent chemoattractant for GATA-3, IL-5
+
Th2 cells in skin allergy, which is in line with our finding of
expression of this chemokine in primarily the perivascular milieu,
where GATA-3 cells were accumulated. Further, the chemokines
Ccl19 may explain the microenvironmental localisation of Treg,
while the chemokines Ccl20 may not explain Th17 cells
distribution [43,46,47]. By Ingenuity Pathways Analysis, we have
documented extensive interactions between the chemokines and
cytokines, suggesting that a small difference in expression of one
may affect the action of the other, and can thus influence the
whole inflammatory network in the microenvironment. This
becomes clearer when some chemokines such as Ccl4 can
influence the traffic of more than one of the studied T effector
cells. The interaction between the different chemokines is
complicated, since we observed a down-regulation of Pf4, which
is related to Th1 responses [48], even though other Th1
chemokines were increased in the same environment.
In summary, our current study shows that T-bet, GATA-3,
Foxp3 and RORct in both CD25
+ and CD25
2 CD4
+ T cells all
expand in lung during allergic airway inflammation, and also
proliferate within the lung. In this mouse model of allergic airway
inflammation, Th2 cells are the most dominant effector T-cell.
Within the lungs, these effector T cells are differently distributed,
with Th1 primarily being present in alveolar lung tissue, Th2 and
Treg cells primarily being observed in perivascular lung tissue, and
the numbers of Th17 cells being few but with a dominance in
peribronchial lung tissue. The inflammatory milieu in those tissue
compartment showed different profiles, both for mediators
associated to allergic inflammation, such as chemokines, explain-
ing at least partly our results. Overall, this study shows that Th2
cells are prominent in allergic inflammation, but also verify
concomitant the activity of Th1, Th2, Th17 and Tregs.
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